Advertisement

Topics

Cempra, Melinta announce merger to form commercial-stage anti-infectives company

15:03 EDT 9 Aug 2017 | CentreWatch

Cempra, Inc., a clinical-stage pharmaceutical company focused on developing differentiated anti-infectives for acute care and community settings to meet critical medical needs in the treatment of infectious diseases, and Melinta Therapeutics, a privately held company focused on discovering, developing and commercializing novel antibiotics to treat serious bacterial infections, have announced that the companies have entered into […]

The post Cempra, Melinta announce merger to form commercial-stage anti-infectives company appeared first on CenterWatch News Online.

Original Article: Cempra, Melinta announce merger to form commercial-stage anti-infectives company

NEXT ARTICLE

More From BioPortfolio on "Cempra, Melinta announce merger to form commercial-stage anti-infectives company"

Quick Search
Advertisement
 

Relevant Topic

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...